Neelja D. Kumar

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f076dd00-43b4-11ee-a7f9-01ad5bafacad.jpg

First Name

Neelja

Last Name

Kumar

NPI

1396911236

Faculty ID

14242

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic Kidney Disease, Renal disease associated with pregnancy, diabetic kidney disease, acute kidney injury, hypertension

Research Focus

Clinical Nephrology and Education

Elsevier Profile

EMR ID

69712

Biography

Neelja Kumar, MD, earned her medical degree at Sophie Davis School of Biomedical Education with Stonybrook Medical Center, New York. She completed her clinical fellowship in Nephrology at Yale School of Medicine, New Haven Connecticut. Dr. Kumar completed her residency in internal medicine at New York University Langone Medical Center and then went on to complete an additional year as chief resident. Dr. Kumar is a board-certified nephrologist and has been part of the faculty at Montefiore since 2014. Dr. Kumar serves as Medical Director at an outpatient dialysis unit in the Bronx. Additionally, Dr. Kumar is an Associate Program Director for the nephrology fellowship program and has worked to enrich the academic curriculum for the clinical fellows. <span style="color:#000000;font-family:Inter, sans-serif;font-size:13.125px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;letter-spacing:normal;orphans:2;text-align:start;text-indent:0px;text-transform:none;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;white-space:pre-wrap;background-color:#f5f5f4;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;display:inline !important;float:none;">Her clinical interests within nephrology include renal disease in the critically ill population and renal disease during pregnancy.</span>

Visit Type ID

2541

Is Open Scheduling

On

Tanya S. Johns

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/346233f0-178e-11ee-be6e-3f9a8c4cef15.jpg

First Name

Tanya

Last Name

Johns

NPI

1699932095

Faculty ID

13910

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic Kidney Disease

Research Focus

Chronic Kidney Disease. Healthcare delivery models, Nutrition

Elsevier Profile

EMR ID

5759

Biography

Tanya Johns, MD, MHS is an Associate Professor of Medicine and a Clinical Investigator in the Department of Medicine/ Division of Nephrology at the Albert Einstein College of Medicine/ Montefiore Medical Center. Dr. Johns earned her medical degree from Weill Medical College of Cornell University and completed Internal Medicine training at NY Presbyterian, where she was also an Assistant Chief Resident. Dr. Johns graduated from the Johns Hopkins Nephrology Fellowship with a Masters in Health Sciences in Clinical Epidemiology. She specializes in care of patients with various kidney disorders and serves as the medical director for Montefiore&rsquo;s Kidney Care Program, an interdisciplinary care clinic for patients with chronic kidney disease. Dr. Johns is an NIH supported researcher and her over-arching research goal is to increase health equity and improve outcomes for all patients with kidney disease.&nbsp;

Visit Type ID

2541

Is Open Scheduling

On

Belinda (Bun) Jim

https://assets.montefioreeinstein.org/profiles/images/9916-belinda-bun-jim.jpg

First Name

Belinda (Bun)

Last Name

Jim

NPI

1639267834

Faculty ID

9916

CMO Specialties

Employment Status

Voluntary

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

63070

Is Open Scheduling

Off

Sonali Gupta

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/ad26aa20-5fbe-11ec-8136-139dc31b73e2.jpg

First Name

Sonali

Last Name

Gupta

NPI

1245683671

Faculty ID

17303

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic kidney disease, hypertension, renal diseases in pregnancy, glomerular disease

Research Focus

Renal diseases in pregnancy, hypertension, chronic kidney disease, medical education

Elsevier Profile

EMR ID

164238

Biography

<p>Sonali Gupta, M.D. completed her medical education at the Lady Hardinge Medical College, New Delhi, India, Residency in Obstetrics and Gynecology at Maulana Azad Medical College, New Delhi, India, followed by an additional year of research in maternal fetal medicine at the University of Tennessee Health Science Center, Memphis. She then completed internal medicine residency at St Vincent&rsquo;s Medical Center, Quinnipiac University Frank H. Netter MD School of Medicine followed by fellowship in nephrology at the University of Rochester and University of Iowa.</p><p>Dr. Gupta is the author of over 35 original articles and 3 book chapters. She has presented her work at various national and international meetings. Dr. Gupta is member of several societies including the American Society of Nephrology. Her clinical expertise is in the area of chronic kidney disease, obstetric nephrology and management of hypertension.<br /></p>

Visit Type ID

2541

Is Open Scheduling

On

Zocdoc Link

Ladan Golestaneh

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/b8ba6930-091d-11ee-9513-abe9ef574488.jpg

First Name

Ladan

Last Name

Golestaneh

NPI

1023199445

Faculty ID

9200

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Ladan Golestaneh received an MD from New York Medical College in 1999.&nbsp; She completed internship and residency at Montefiore Medical Center in 2002 and a nephrology fellowship at Einstein in 2004.</p>
<p>Following fellowship, Dr. Golestaneh was hired as clinical instructor in the Einstein Division of Nephrology, where she set up the first critical care/ nephrology subspecialty Einstein/Montefiore and introduced continuous dialysis therapies at Montefiore. She was promoted to assistant professor in 2005 and associate professor status in 2012, and full professor in 2019.</p>
<p>Dr. Golestaneh holds various administrative positions within the Division of Nephrology and Department of Medicine including service as Medical Director of two large hemodialysis centers and director of the largest home dialysis program in the Bronx. Her research interests include acute kidney injury (AKI) and the cardiorenal and hepatorenal syndromes.</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4248

Is Open Scheduling

On

Molly C. Fisher

https://assets.montefioreeinstein.org/profiles/images/physphoto/Fisher_Molly_DO_420x504.jpg

First Name

Molly

Last Name

Fisher

NPI

1467749143

Faculty ID

15914

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

General Nephrology and Hypertension

Research Focus

Dr. Fisher's main research interest is understanding the susceptibility to kidney injury and disease among people living with HIV. She has led several clinical research studies defining risk factors and outcomes following acute kidney injury among patients with COVID-19.

Elsevier Profile

Lab Website Link

Selected Publications

<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif; line-height: 12.65pt;"><strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">HIV and Kidney Disease</span></strong></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif; color: #212121; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Edrosolan KA, Shlipak MG, Scherzer R, Estrella MM, Gustafson D, Karim R, <strong><u>Fisher M</u></strong>, Cohen M, Kassaye S, Dumond J, Abraham A, McCulloch CE, Ascher SB. Mediation analysis of chronic kidney disease risk factors using kidney biomarkers in women living with HIV. AIDS. 2024 May 1;38(6):813-824</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif;">Fisher M*</span></u></strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">, Hoover D, Shi Q, Sharma A, Estrella M, Adimora A, Alcaide M, Collins L, French A, Gao W, Koletar S, McFarlane S, McKay H, Dionne-Odom J, Palella F, Sarkar S, Spence A, Witt M, Ross M.&nbsp;Association of marijuana, tobacco and alcohol use with estimated glomerular filtration rate in women living with HIV and women without HIV.&nbsp;<em>AIDS</em>. 2023;37(10):1555-1564.&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Banerjee T, Frongillo E,&nbsp;<span style="border: 1pt none windowtext; padding: 0in;">Turan&nbsp;</span>J, Sheira L,&nbsp;<span style="border: 1pt none windowtext; padding: 0in;">Adedimeji&nbsp;</span>A,&nbsp;<span style="border: 1pt none windowtext; padding: 0in;">Wilson T, Merenstein D, Cohen M, Adimora&nbsp;</span>A,&nbsp;<span style="border: 1pt none windowtext; padding: 0in;">Ofotokun I,&nbsp;<span style="background: #f9f9f9;">Metsch&nbsp;</span></span>L,&nbsp;<span style="border: 1pt none windowtext; padding: 0in;">D&rsquo;Souza&nbsp;</span>G,&nbsp;<span style="border: 1pt none windowtext; padding: 0in;">Fischl&nbsp;</span>M,&nbsp;<strong><u>Fisher M</u></strong>, Tien P, Weiser S&nbsp;Association of Higher Intake of Plant-Based Foods and Protein With Slower Kidney Function Decline in Women With HIV.&nbsp;<em>J Acquir Immune Defic Syndr</em>. 2023;94(3):203-210.</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif; color: #212121;">Fisher MC*</span></u></strong><span style="font-size: 11pt; font-family: Arial, sans-serif; color: #212121;">, Fazzari MJ, Felsen UR, et al. Association of HIV and viral suppression status with hospital acute kidney injury in the era of antiretroviral therapy [published online ahead of print, 2023 Aug 19].&nbsp;<em>Kidney Int</em>. 2023;S0085-2538(23)00560-4</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif; line-height: 12.65pt;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Wyatt C,&nbsp;<strong><u>Fisher M</u></strong>, Klotmann P, (2023) HIV-associated Nephropathy (HIVAN). R Glassock &amp; A Fornoni (Ed). UpToDate&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Wyatt C,&nbsp;<strong><u>Fisher M</u></strong>, Klotmann P, (2023) Human Immunodeficiency Virus and Dialysis. S Schwab &amp; M Hirsch (Ed). UpToDate&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif; line-height: 12.65pt;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif;">Fisher M*</span></u></strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">, Fazzari MJ, Hanna DB, Patel VV, Felsen UR, Alahiri E, Akiyama MJ, Byju A, Ginsberg MS, Anastos K, Ross M Acute Kidney Injury in People Living with HIV Hospitalized with COVID-19: Clinical Characteristics and Outcomes&nbsp;<em>J Acquir Immune Defic Syndr</em>. 2021 Aug 15;87(5):1167-1172 [PMID: 34229329]</span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif; line-height: 12.65pt;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Prudhvi K, Schwartz D,&nbsp;<strong><u>Fisher M</u>.&nbsp;</strong>Rituximab for Lupus-Like Membranous Nephropathy in the Setting of Well-Controlled HIV Infection.&nbsp;<em>Am J Ther.</em>&nbsp;2020 Aug 3.&nbsp;[PMID: 32769387]</span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif; line-height: 12.65pt;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif; vertical-align: baseline;"><strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">COVID-19 and Kidney Disease&nbsp;</span></strong></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif; vertical-align: baseline;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif; vertical-align: baseline;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Reis T<strong>,&nbsp;<u>Fisher M</u></strong>, Nast C, Ross M (2023) Chapter 59: Kidney Diseases Associated with Corona Viruses. In Johnson (Editor) Comprehensive Clinical Nephrology (7^th&nbsp;edition).&nbsp;Elsevier. Publication date: March 15, 2023.</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif; vertical-align: baseline;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif; vertical-align: baseline;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Lu^&nbsp;J, Boparai^&nbsp;MS, Shi^&nbsp;C, Henninger^&nbsp;EM, Rangareddy^&nbsp;M, Veeraraghavan^&nbsp;S, Mirhaji^&nbsp;P,&nbsp;<strong><u>Fisher^&nbsp;M</u></strong>, Duong TQ&nbsp;Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI [published online ahead of print, 2023 Jan 25].&nbsp;<em>Nephrol Dial Transplant</em>. 2023;gfad020. doi:10.1093/ndt/gfad020</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif; vertical-align: baseline;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Liu D, Mowrey W,&nbsp;<strong><u>Fisher M</u></strong>, Basaley A, McCarthy J, Kumar N, Thakkar J, Azzi Y, Brogan M, Golestaneh L, Reidy K, Chen W Association of Dysnatremias and COVID-19 Status with Mortality&nbsp;<em>Kidney360</em>&nbsp;Published Ahead of Print, published on June 3, 2022 as doi:10.34067/KID.0001062022</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif; vertical-align: baseline;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Lu JY, Buczek A, Fleyster R, Hoogenboom W, Hou W, Rodriguez C,&nbsp;<strong><u>Fisher M</u></strong>, Duong T Outcomes of Hospitalized Patients with COVID-19 with Acute Kidney Injury and Acute Cardiac Injury&nbsp;<em>Front Cardiovasc Med</em>. 2022;8:798897&nbsp;</span><span style="font-size: 11pt; font-family: Arial, sans-serif; color: #212121;">Published 2022 Feb 15 [PMID:&nbsp;35242818]</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Lu J, Babatsikos I,&nbsp;<strong><u>Fisher M</u></strong>, Hou W, Duong T Longitudinal Clinical Profiles of Hospital- versus Community-acquired Acute Kidney Injury in COVID-19&nbsp;Front Med (Lausanne). 2021 May 28;8:647023&nbsp;[PMID: 34124089]</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif;"><a name="_Hlk43119894"></a><span style="font-size: 11pt; font-family: Arial, sans-serif;">Patel VV, Felsen UR,&nbsp;<strong><u>Fisher M</u></strong>, Fazzari MJ, Ginsberg MS, Beil R, Akiyama MJ, Anastos K, Hanna DB. Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19.&nbsp;<em>J Acquir Immune Defic Syndr</em>. 2021 Feb 1;86(2):224-230 [PMID&nbsp;33433966]</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Golestaneh L, Neugarten J,&nbsp;<strong><u>Fisher M</u></strong>, Billett HH, Gil MR, Johns T, Yunes M, Mokrzycki MH, Coco M, Norris KC, Perez HR, Scott S, Kim RS, Bellin E.&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pubmed/32838233/"><span style="color: black;">The association of race and COVID-19 mortality.</span></a>&nbsp;<em>EClinicalMedicine</em>.&nbsp;2020; Aug;&nbsp;25:100455.&nbsp;doi:10.1016/j.eclinm.2020.100455.&nbsp;Epub 2020 Jul 15&nbsp;[PMID: 32838233]</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif;">Fisher M*</span></u></strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">, Neugarten J, Bellin E et al Acute Kidney Injury in Hospitalized Patients with and without COVID-19: A Comparison Study&nbsp;<em>J Am Soc Nephrol</em>&nbsp;2020; 31(9):2145-2157&nbsp; [PMID:&nbsp;</span><span style="font-size: 11pt; font-family: Arial, sans-serif; color: #212121;">32669322]</span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif; line-height: 12.65pt;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif;">Fisher M*</span></u></strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">, Yunes M, Mokrzycki M, Golestaneh L, Alahiri E, Coco M Chronic Hemodialysis Patients Hospitalized with COVID-19 &ndash; Short-term Outcomes in the Bronx, New York&nbsp;<em>Kidney360</em>&nbsp;2020;&nbsp;<span style="border: 1pt none windowtext; padding: 0in;">1(8):&nbsp;755-762;&nbsp;https://doi.org/10.34067/KID.0003672020</span></span></p&gt;
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif; line-height: 12.65pt;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif;">Fisher M*</span></u></strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">, Prudhvi K, Brogan M, Golestaneh L Providing care to patients with acute kidney injury and COVID-19 infection: Experience from nephrologists on the front line in New York&nbsp;<em>Kidney360</em>, 2020;&nbsp;<span style="border: 1pt none windowtext; padding: 0in;">1(6):&nbsp;544-548;&nbsp;https://doi.org/10.34067/KID.0002002020</span></span></p&gt;
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif; line-height: 12.65pt;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif; line-height: 12.65pt;"><strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">Vascular Access in Dialysis Patients&nbsp;</span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; font-size: 12pt; font-family: Aptos, sans-serif; line-height: 12.65pt;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif;">Fisher M</span></u></strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">, Golestaneh L, Allon M, Abreo K, Mokrzycki M. Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis.&nbsp;<em>Clin J Am Soc Nephrol</em>&nbsp;2020; 15(1): 132-151&nbsp;[PMCID: PMC6946076]</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif;">Fisher M*</span></u></strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">, Mokrzycki M (2022). Chapter 20: Infectious Complications from Vascular Access [E-book]. In A.R. Nissenson, R.N. Fin, R. Mehotra, &amp; J. Zaritsky (Editors), Handbook of Dialysis and Therapy (6^th&nbsp;edition). Elsevier.</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">Editorials in Kidney Disease</span></strong></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif; color: #212121;">Fisher M</span></u></strong><span style="font-size: 11pt; font-family: Arial, sans-serif; color: #212121;">, Aklilu A, Ying Ng Ng MS, Spires D, Vieira MB. A Glimpse into an Editorial Training Program: from the Kidney360 Editorial Program Trainees [published online ahead of print, 2023 Nov 20].&nbsp;<em>Kidney360</em>. 2023;10.34067/KID.0000000000000311.&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">*Corresponding author</span></p>

EMR ID

56895

Biography

Molly Fisher, D.O., is an Assistant Professor of Medicine in the Division of Nephrology at Montefiore Medical Center/ Albert Einstein College of Medicine. She earned her medical degree at Des Moines University in Des Moines, Iowa in 2011. She then completed her internal medicine residency at Stamford Hospital/ Columbia University College of Physicians and Surgeons in 2014, followed by a nephrology fellowship at Montefiore Medical Center/ Albert Einstein College of Medicine in 2017. Dr. Fisher is board certified in internal medicine and nephrology. Her areas of clinical expertise include management of resistant hypertension, out-of-office blood pressure monitoring and virally mediated kidney disease. She is a certified hypertension specialist and is the Director of the Montefiore Ambulatory Blood Pressure Monitoring Program and the Nephrology Division Remote Blood Pressure Monitoring Program. She also leads an HIV-Kidney Disease Clinic at the AIDS Center for Positive Living, one of the largest HIV clinics in the United States. She is an active member of the American Society of Nephrology and serves on the ASN In-Training Exam Committee.

Visit Type ID

2541

Is Open Scheduling

On

Mary J. Dominguez

https://assets.montefioreeinstein.org/profiles/images/physphoto/Dominiquez_Mary_MD_420x504.jpg

First Name

Mary

Last Name

Dominguez

NPI

1043568835

Faculty ID

15755

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

CKD, Diabetic kidney disease, HTN, Glomerulonephritis, Lupus Nephritis, Electrolytes, and acid base disorders, ADPKD

Research Focus

Lupus Nephritis

Elsevier Profile

EMR ID

76889

Biography

Mary J. Dominguez, MD received her medical degree at Pontificia Universidad Catolica Madre y Maestra at her hometown of Santiago, Dominican Republic in 2008. She completed her internal medicine internship at New York Downtown Hospital in 2013 and her internal medicine residency at Winthrop University hospital in 2015. Dr. Dominguez then completed a fellowship in nephrology at Montefiore Medical Center and joined as faculty in 2017 as an Assistant Professor of Medicine.<br />&nbsp;<br />Her areas of interest include CKD care, glomerulonephritis, lupus nephritis and medical education. She has a special interest in lupus nephritis and serves as the lead nephrologist at Montefiore-Einstein Lupus Institute for Lupus Care and Research. Since 2022, Dr. Dominguez has served as the Assistant Program Director of the nephrology fellowship program and is the Director of one of the fellow clinics.<br />

Visit Type ID

2541

Is Open Scheduling

On

Maria Coco

https://assets.montefioreeinstein.org/profiles/images/4829-maria-coco.jpg

First Name

Maria

Last Name

Coco

NPI

1649360546

Faculty ID

4829

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic Kidney Disease<br />Renal Replacement Therapy<br />Acute Kidney Disease and Glomerulonephritis<br />Specialized Kidney Biopsies to diagnose and tailor treatment of kidney disease<br />Metabolic Bone Disease in patients with Kidney Disease<br />Metabolic Bone Disease and Osteoporosis in Transplant Patients<br />Specialized Bone Biopsies to diagnose and tailor treatment&nbsp;<br />

Research Focus

Dr. Coco&rsquo;s main research interest is investigating metabolic bone disease in patients with renal disease and organ transplantation. Dr. Coco has investigated the effect of bone modulators or medications on improving bone dynamics and strength. She has collaborated with national and international forums to establish treatment guidelines.

Elsevier Profile

Selected Publications

<p><ol>
<li>Suji Lee, Maria Coco, Stuart Greenstein, Richard Schechner, Vivian Tellis, Daniel Glicklich. The effect of rapamycin on sex hormone levels of male renal transplant recipients. Clin Transplant 19(2): 162-7, 2005</li>
<li>Amanda Raff, Tiffany Hebert, James Pullman, Maria Coco. Crescentic oststreptococcal glomerulonephritis with nephrotic syndrome in the adult: is aggressive therapy warranted? Clin Nephrol 63 (5): 375-80, 2005</li>
<li>Shapiro C, Coco M. Gastric calciphylaxis in a patient with a functioning renal allograft. Clin Nephrol. Feb;67(2):119-25. 2007</li>
<li>Coco M. Treating the renal patient who has a fracture: opinion vs evidence. Cleve Clin J Med. 2009 Dec;76(12):684-8.</li>
<li>Miller PD, Coco M. Fragility fractures in chronic kidney disease: A clarification of views (December 2009). Cleve Clin J Med. Feb;77(2):75, 2010.</li>
</ol></p>

EMR ID

3564

Biography

Dr. Maria Coco earned her medical degree from the University of Rome, Italy. She completed an Internal Medicine Degree at Bronx Lebanon Hospital Center in Bronx, NY. She completed a renal fellowship at Montefiore Medical Center followed by a renal research fellowship at Montefiore Medical Center. She completed a masters program (MS) in Clinical Research Methods at Albert Einstein College of Medicine in the Bronx. Dr. Coco trained in Bone Biopsy methods in Copenhagen, Denmark.&nbsp;<br />Dr. Coco is board certified by the American Board of Internal Medicine and the American Board of Nephrology.<br />Dr. Coco has mentored many fellows in the practice of Bone Biopsy, ensuring that the treatment of metabolic bone disease is based on evidence.<br />Dr. Coco has authored and co-authored many peer-reviewed papers on complex issues in renal disease and bone disease.<br />

Visit Type ID

2541

Is Open Scheduling

On

Wei Chen

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/c5ea9870-2b53-11ee-856e-7796aa695fa6.jpg

First Name

Wei

Last Name

Chen

NPI

1518255421

Faculty ID

12898

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal"><strong><span style="font-size: 14.0pt; line-height: 107%; color: #4472c4; mso-themecolor: accent1;">Research overview</span></strong></p>
<p class="MsoNormal">Thirty million people in the United States are estimated to have chronic kidney disease (CKD). In patients with CKD, arterial calcification (pathological deposition of calcium phosphate salts into the arterial walls) is common, with a prevalence approaching 80%, and may contribute to their high cardiovascular mortality. The long-term goal of our research program is to understand the pathophysiology of arterial calcification and to develop new treatment strategies for it.</p>
<p class="MsoNormal">Our research program includes: 1) the role of calciprotein particles (CPPs) in the development of arterial calcification. CPPs are nanoparticles that are composed of calcium phosphate crystals and calcification inhibitors. They are thought to mediate the transport and clearance of excess calcium and phosphate in circulation. Using a new, microplate -based, dynamic light scattering assay, we measured both the size of secondary CPPs and transformation time and investigate the role of CPPs in arterial calcification using human vascular smooth muscle cells and CKD patient cohorts. 2) the role of cellular interaction in arterial calcification. Studying the paracrine signaling between endothelial cells and vascular smooth muscle cells will help identify novel therapeutic targets that attenuate vascular calcification without adverse effects on bone mineralization.</p>
<p class="MsoNormal"><strong><span style="font-size: 14.0pt; line-height: 107%; color: #4472c4; mso-themecolor: accent1;">Medical education</span></strong></p>
<p class="MsoNormal"><span style="color: #222222;">2008: MD, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY</span></p>
<p class="MsoNormal"><span style="color: #222222;">2014: MSc in Clinical Research Methods, Albert Eisntein College of Medicine, Bronx, NY</span></p>
<p class="MsoNormal"><strong><span style="font-size: 14.0pt; line-height: 107%; color: #4472c4; mso-themecolor: accent1;">Post-graduate training</span></strong></p>
<p class="MsoNormal"><span style="color: #222222;">2011: Internal medicine residency, Montefiore Medical Center, Bronx, NY</span></p>
<p class="MsoNormal"><span style="color: #222222;">2014: Nephrology fellowship (research track), Montefiore Medical Center, Bronx, NY</span></p>
<p class="MsoNormal"><strong><span style="font-size: 14.0pt; line-height: 107%; color: #4472c4; mso-themecolor: accent1;">Honors</span></strong></p>
<p class="MsoNormal">2015: University of Rochester Clinical and Translational Award (NIH KL2)</p>
<p class="MsoNormal">2017: Fellow of the American Society of Nephrology</p>
<p class="MsoNormal">2017: American Society of Nephrology Carl W. Gottschalk Research Scholar</p>
<p class="MsoNormal">2018: NIH Mentored Patient-Oriented Research Career Development Award (NIH K23)</p>
<p class="MsoNormal">2019: Chinese American Society of Nephrology Young Investigator Award</p>
<p class="MsoNormal">2022: NIH-Small Grant Program for NIDDK K Recipients (NIH R03)</p>
<p class="MsoNormal">2024: NIH-R01HL172073</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic kidney disease<br />Kidney stone disease<br />Mineral and bone disease associated with kidney disease&nbsp;<br />

Research Focus

Vascular calcification is prevalent and accelerated among patients with chronic kidney disease and contributes to the high cardiovascular mortality. Dr. Chen&rsquo;s lab focuses on identification of novel biomarkers and therapeutic targets for vascular calcification.

Elsevier Profile

Lab Website Link

Selected Publications

<h3><span style="color: black;">Vascular calcification and mineral metabolism</span></h3>
<p><!-- [if !supportLists]-->Zaslow SJ, Oliveira-Paula GH, <strong>Chen W</strong>*. &ldquo;Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights&rdquo;. <em>International Journal of Molecular Sciences</em>. 2024, 25, 1155. https://doi.org/10.3390/ijms25021155</p&gt;
<p class="MsoNormal"><a name="_Hlk128664663"></a>Xie Y, Mossavar-Rahmani Y, Chen Y, Abramowitz MK, <strong>Chen W</strong>*. &ldquo;Association of dietary potassium intake with abdominal aortic calcification and pulse pressure in US adults.&rdquo; <em>Journal of Renal Nutrition</em>. 2023 Jun 9;S1051-2276(23)00093-6. doi: 10.1053/j.jrn.2023.06.003. Online ahead of print.</p>
<p><span style="color: black;"><strong>Chen W</strong>*, Chen Y. &ldquo;Cardiometabolic syndrome and vascular calcification.&rdquo; <em>The CardioMetabolic Syndrome Journal</em>. 2022. https://doi.org/10.51789/cmsj.2022.2.e2</span></p&gt;
<p class="MsoNormal" style="margin-right: .2in;"><a name="_Hlk41571072"></a><strong>Chen W*</strong>, Fitzpatrick J, Sozio SM, Jaar BG, Estrella MM, Riascos-Bernal DF, Wu TT, Qiu Y, Kurland IJ, Dubin RF, Parekh RS, Chen Y, Bushinsky DA, Sibinga NES. &ldquo;Identification of Novel Biomarkers and Pathways for Coronary Arterial Calcification in Patients on Hemodialysis using Metabolomic Profiling.&rdquo; <em>Kidney360. </em>2021.&nbsp;<a style="font-family: 'Times New Roman', serif; font-size: 12pt;" href="https://kidney360.asnjournals.org/content/early/2020/12/04/KID.00044220… style="font-family: 'Times New Roman', serif; font-size: 12pt;"> [ePub before print]</span></p>
<p class="MsoNormal" style="margin-right: .2in;"><strong>Chen W*</strong>, Fitzpatrick J, Monroy-Trujillo JM, Sozio SM, Jaar BG, Estrella MM, Serrano J, Anokhina V, Miller BL, Melamed ML, Bushinsky DA, Parekh RS. &ldquo;Associations of Serum Calciprotein Particle Size and Transformation Time with Arterial Calcification, Arterial Stiffness and Mortality in Incident Hemodialysis Patients.&rdquo; <em>American Journal of Kidney Diseases. </em>2020 DOI:https://doi.org/10.1053/j.ajkd.2020.05.031&nbsp;</p&gt;
<p class="MsoNormal"><span style="color: black;">Riascos-Bernal DF, Becher T, Kramer DJ, Almonte VM, Chi J, Tong T, Oliveira-Paula GH, Koleilat I,&nbsp;<strong>Chen W</strong>, Cohen P, Sibinga NES. &ldquo;Three-dimensional Imaging Provides Detailed Atherosclerotic Plaque Morphology 1 and Reveals Angiogenesis after Carotid Artery Ligation.&rdquo;&nbsp;<em>Circulation Research.</em>&nbsp;2020 Jan 9. https://www.ahajournals.org/doi/abs/10.1161/CIRCRESAHA.119.315804&nbsp;…;
<p class="MsoNormal"><strong><span style="color: black;">Chen W*</span></strong><span style="color: black;">, Eisenberg R, Mowrey WB, Wylie-Rosett J, Abramowitz MK, Bushinsky DA, Melamed ML. &ldquo;Association Between Dietary Zinc Intake and Abdominal Aortic Calcification in US Adults.&rdquo;&nbsp;<em>Nephrology Dialysis Transplantation.</em>&nbsp;2019 Jul 11. pii: gfz134. doi: 10.1093/ndt/gfz134. [Epub ahead of print]. PMID: 31298287</span></p>
<p class="MsoNormal"><strong><span style="color: black;">Chen W*</span></strong><span style="color: black;">, Fitzpatrick J, Monroy-Trujillo JM, Sozio SM, Jaar BJ, Estrella MM, Wu TT, Melamed ML, Parekh RS, Bushinsky DA. &ldquo;Diabetes Mellitus Modifies the Associations of Serum Magnesium Concentration with Arterial Calcification and Stiffness in Incident Hemodialysis Patients&rdquo;.&nbsp;<em>Kidney International Reports, 2019.</em>&nbsp;DOI: https://doi.org/10.1016/j.ekir.2019.03.003</span></p&gt;
<p class="MsoNormal"><strong><span style="color: black;">Chen W*</span></strong><span style="color: black;">, Anokhina V, Dieudonne G; Abramowitz MK, Kashyap R, Yan C, Wu TT, Bentley KL, Miller B, &nbsp;Bushinsky DA. "Patients with Advanced Chronic Kidney Disease and Vascular Calcification Have a Large Hydrodynamic Radius of Secondary Calciprotein Particles".&nbsp;<em>Nephrology Dialysis Transplantation</em>&nbsp;(2018). Doi:10.1093/ndt/gfy117. PMID: 29788425</span></p>
<p class="MsoNormal"><span style="color: black;"><strong>Chen W*</strong>, Newman AB, Fried LF, Rifkin DE, Shlipak M, Sarnak MJ, Katz R, Madero M, Raphael KL, Bushinsky DA, Ix JH. &ldquo;Relationship of Acid-Base Status with Arterial Stiffness in Community-Living Elders: the Health ABC Study&rdquo;.&nbsp;<em>Nephrology Dialysis Transplantation</em>&nbsp;(2017) 1-8. Doi: 10.1093/ndt/gfx292. PMID: 29177410.</span></p>
<p class="MsoNormal"><strong>Chen W</strong>,&nbsp;Bushinsky DA. "KDIGO CKD-MBD Guideline Update: Evolution in the Face of Uncertainty".&nbsp;<em>Nature Reviews Nephrology</em>. 2017 Aug 21. doi: 10.1038/nrneph.2017.118. [Epub ahead of print] PubMed PMID: 28824172.</p>
<p class="MsoNormal"><strong>Chen W</strong>, Bushinsky DA. "The Perils of a Falling PTH due to High Dialysate Calcium".&nbsp;<em>Nature Reviews Nephrology</em>, 2016 May; 12(5):264-6. doi:10.1038/nrneph.2016.36. PMID: 26996329.</p>
<p class="MsoNormal"><strong>Chen W</strong>, Melamed ML. "Vascular Calcification in Pre-Dialysis CKD: Common and Deadly".&nbsp;<em>Clinical Journal of the American Society of Nephrology,</em> 2015 Apr 7;10(4):551-3.</p>
<p class="MsoNormal"><strong>Chen W</strong>, Bushinsky DA.&nbsp;<em>Handbook of Dialysis Therapy</em>. 5th edition. Nissenson AR, Fine RN, editors. Chapter 59. "Overview of Chronic Kidney Disease and Bone Disorder".&nbsp;</p>
<p class="MsoNormal"><strong>Chen W</strong>, Monk RD, Bushinsky DA.&nbsp;<em>Comprehensive Clinical Nephrology</em>. 6^th&nbsp;edition. Johnson RJ, Feehally J, Floege J, editors. Chapter 57. "Nephrolithiasis and Nephrocalcinosis".&nbsp;</p>
<h3 class="MsoNormal"><span style="color: black;">Metabolic acidosis in CKD</span></h3>
<p class="MsoNormal"><strong>Chen W*</strong>, Melamed ML, Hostetter TH, Bauer C, Raff AC, Almudevar AL, Lalonde A, Messing S, Abramowitz MK. &ldquo;Effect of Oral Sodium Bicarbonate on Fibroblast Growth Factor-23 in Patients with Chronic Kidney Disease: A Pilot Study&rdquo;. <em>BMC Nephrology</em> (2016) 17:114. PMID: 27495287.</p>
<p class="MsoNormal" style="margin-right: .2in;"><strong>Chen W*</strong>, Melamed ML, Abramowitz MK. &ldquo;Serum Bicarbonate Level and Bone Mineral Density in the United States Adults&rdquo;. <em>American Journal of Kidney Diseases</em>, 2015 Feb;65(2):240-8. PMID: 25168294.</p>
<p class="MsoNormal" style="margin-right: .2in;"><a name="_Hlk41571103"></a>Gone AR, <strong>Chen W*</strong>. &ldquo;Veverimer for Treatment of Chronic Metabolic Acidosis in Patients with Chronic Kidney Disease.&rdquo; <em>Annals of Translational Medicine. </em>2020. doi: 10.21037/atm-20-3320. [In press]</p>
<p class="MsoNormal"><strong>Chen W*</strong>, Levy DS, Abramowitz MK. &ldquo;Acid-base Balance in the Progression of Chronic Kidney Disease&rdquo;. <em>Seminars in Nephrology</em>, 2019 Jul;39(4):406-417.</p>
<p class="MsoNormal"><strong style="mso-bidi-font-weight: normal;">Chen W*</strong>, Abramowitz MK. &ldquo;Advances in management of chronic metabolic acidosis in CKD.&rdquo; <em style="mso-bidi-font-style: normal;">Current Opinion in Nephrology and Hypertension</em>. 2019 Jun 19. doi: 10.1097/MNH. 0000000000000524. [Epub ahead of print]. PMID: 31232712.</p>
<p class="MsoNormal"><strong>Chen W</strong>, Bushinsky DA. &ldquo;Addressing Racial Disparity in the Progression of CKD: Prescribe More Fruits and Vegetables?&rdquo; <em>American Journal of Nephrology</em>. 2018 Mar 13;47(3):171-173. doi: 10.1159/000487716. PMID: 29533958.</p>
<p class="MsoNormal"><strong>Chen W</strong>, Abramowitz MK. &ldquo;Epidemiology of Acid-Base Derangements in CKD&rdquo;. <em>Advances in Chronic Kidney Disease</em>. 2017;24(5):280-288. PMID: 29031354.</p>
<p class="MsoNormal" style="margin-right: .2in;"><strong>Chen W</strong>, Abramowitz MK. &ldquo;Metabolic Acidosis and the Progression of Chronic Kidney Disease&rdquo;. <em>BMC Nephrology</em>, 15:55, 2014. PMID: 24708763.</p>
<p class="MsoNormal" style="margin-right: .2in;"><strong>Chen W</strong>, Abramowitz MK. &ldquo;Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease, an Acid-Base and Electrolyte Teaching Case&rdquo;. <em>American Journal of Kidney Disease</em>, 63(2):311-317, 2014. PMID: 23932089.</p>
<h3>Nephrology and COVID-19 pandemic</h3>
<p>Sourial M, Gone AR, Uribarri J, Srivatana V, Sharma S, Shimonov D, Chang M, Mowrey W, Dalsan R, Sedaliu K, Jain S, Ross MJ, Caplin NJ,<strong> Chen W</strong>. &ldquo;Outcomes of PD for AKI Treatment During COVID-19 in New York City: A Multicenter Study.&rdquo; <em>Peritoneal Dialysis International</em> November 2022 https://doi.org/10.1177/08968608221130559</p&gt;
<p class="MsoNormal">Liu D, Mowrey W, Fisher M, Basalely AM, Kumar ND, Thakkar J, Azzi Y, Brogan M, Golestaneh L, Reidy KJ, <strong>Chen W</strong>. &ldquo;Associations of Dysnatremia with COVID-19 status and Mortality.&rdquo; <em>Kidney360</em>. June 2022, 10.34067/KID.0001062022; DOI: https://doi.org/10.34067/KID.0001062022</p&gt;
<p class="MsoNormal"><strong>Chen W</strong>*, Caplin N, El Shamy O, Sharma S, Sourial MY, Ross M, Sourial MH, Prudhvi K, Golestaneh L, Srivatana V, Dalsan R, Shimonov D, Sanchez-Russo L, Atallah S, Uribarri J on behalf of NYC-PD Consortium. &ldquo;Use of Peritoneal Dialysis for Acute Kidney Injury during the COVID-19 Pandemic in New York City: A multicenter observational study&rdquo;.&nbsp;<em>Kidney International</em>&nbsp;April 2021 https://www.kidney-international.org/article/S0085-2538(21)00456-7/full…;
<p class="MsoNormal" style="background: white; margin: 12.0pt 0in 12.0pt 0in;"><a name="_Hlk41571128"></a><span style="mso-fareast-font-family: 'Times New Roman';">Sourial MY, Sourial MH, Dalsan R, Grahma J, Ross M, <strong>Chen W</strong>, Golestaneh L. &ldquo;Urgent Peritoneal Dialysis in Patients with COVID-19 and AKI: A Single-Center Experience in a Time of Crisis in the United States.&rdquo; </span><em>American Journal of Kidney Diseases</em><span style="mso-bookmark: _Hlk41571128;"><span style="mso-fareast-font-family: 'Times New Roman';"> 2020 Sep;76(3):401-406. PMID: 32534129.</span></span></p>
<p class="MsoNormal" style="background: white; margin: 12.0pt 0in 12.0pt 0in;"><span style="mso-bookmark: _Hlk41571128;"><span style="mso-fareast-font-family: 'Times New Roman';">*corresponding author</span></span></p>

EMR ID

74353

Biography

<p>Wei Chen, MD, is an attending physician and Associate Professor, Medicine (Nephrology) and Developmental &amp; Molecular Biology at Montefiore Einstein. Dr. Chen&rsquo;s clinical focus is in the treatment of kidney disease, kidney stones and vascular calcification, as well as dialysis.</p><p>After completing her Bachelor of Science in biology at Saint John&rsquo;s University, Dr. Chen pursued her Doctor of Medicine at Renaissance School of Medicine Stony Brook University, completing it in 2008. She came to Einstein for her internship and residency in internal medicine from 2008 to 2011, then continued at Einstein to complete a three-year nephrology fellowship as well as her Master of Science in clinical research methods in 2014.</p><p>Dr. Chen&rsquo;s research studies vascular calcification in patients with chronic kidney disease using bench-to-bedside translational approaches. She has shared her research through several peer-reviewed publications, abstracts, editorials, book chapters and regional, national and international presentations.</p><p>Dr. Chen is board certified in Internal Medicine and Nephrology by the American Board of Internal Medicine. She is a Fellow of the American Society of Nephrology and a member of several professional organizations including the American Heart Association, the North American Vascular Biology Organization and the Chinese American Society of Nephrology. In 2019, she was recognized at Montefiore Einstein with the Department of Medicine Rising Star award. In 2022, she was honored as a Department of Medicine Faculty Scholar.</p>

Is Open Scheduling

On

Maureen E. Brogan

https://assets.montefioreeinstein.org/profiles/images/physphoto/Brogan_Maureen_MD_420x504.jpg

First Name

Maureen

Last Name

Brogan

NPI

1053311209

Faculty ID

4491

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic kidney disease, glomerular diseases, hypertension, kidney stones, electrolyte abnormalities

Research Focus

Clinical Nephrology and Education

Elsevier Profile

EMR ID

44144

Biography

<p>Maureen Brogan MD did her Internal Medicine residency and Nephrology fellowship at Montefiore Medical Center/Albert Einstein College of Medicine.<br />She served as the Nephrology Training Program Director at New York Medical College for 11 years and returned to Montefiore Medical Center in 2018.&nbsp;</p><p>At Montefiore Medical Center, she took on the role as the Clinical Director of the Nephrology Division and Program Director of the Nephrology Advanced Care Practitioners in 2019. Dr. Brogan is also an Outpatient Dialysis Medical Director and the Acute Dialysis Director for the Intensive Care Unit.<br /></p>

Visit Type ID

2541

Is Open Scheduling

On

Zocdoc Link